ENTITY

Remegen (688331 CH)

105
Analysis
Health Care • China
RemeGen Co., Ltd. operates biotechnology businesses. The Company develops therapeutic antibody drugs such as antibody drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and double antibodies. RemeGen provides solutions autoimmune diseases, tumor diseases, and ophthalmic diseases.
more
Company Event • 30 Oct 2026 16:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 25 Mar 2027 09:30 • Upcoming
Add To Calendar

Q4 2026

Company Event • 24 Aug 2026 22:40 • Upcoming
Add To Calendar

Q2 2026

Company Event • 28 Apr 2026 16:00 • Upcoming
Add To Calendar

Q1 2026

Company Event • 27 Mar 2026 15:30 • Upcoming
Add To Calendar

Q4 2025

x